Hills Bank & Trust Co Raises Stock Position in Bath & Body Works, Inc. $BBWI

Hills Bank & Trust Co grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 10.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,267 shares of the company’s stock after buying an additional 3,123 shares during the period. Hills Bank & Trust Co’s holdings in Bath & Body Works were worth $967,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the company. Parallel Advisors LLC boosted its stake in shares of Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares during the period. Natixis Advisors LLC boosted its stake in shares of Bath & Body Works by 0.7% during the 1st quarter. Natixis Advisors LLC now owns 90,089 shares of the company’s stock worth $2,732,000 after purchasing an additional 629 shares during the period. 1834 Investment Advisors Co. boosted its stake in shares of Bath & Body Works by 4.9% during the 1st quarter. 1834 Investment Advisors Co. now owns 16,736 shares of the company’s stock worth $507,000 after purchasing an additional 779 shares during the period. Geneos Wealth Management Inc. boosted its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Bath & Body Works by 1.5% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 53,593 shares of the company’s stock worth $1,625,000 after purchasing an additional 809 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

Shares of BBWI opened at $24.48 on Friday. Bath & Body Works, Inc. has a 1-year low of $23.49 and a 1-year high of $41.87. The company has a 50-day moving average of $27.01 and a 200 day moving average of $28.98. The firm has a market capitalization of $5.05 billion, a price-to-earnings ratio of 7.26, a PEG ratio of 0.86 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the business posted $0.37 EPS. The firm’s revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a $0.20 dividend. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 3.3%. Bath & Body Works’s payout ratio is currently 23.74%.

Analysts Set New Price Targets

A number of equities analysts recently commented on BBWI shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Barclays dropped their price target on shares of Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a research note on Monday, October 20th. Jefferies Financial Group dropped their price target on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research note on Monday, October 13th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $26.00 price target on shares of Bath & Body Works in a research note on Monday, October 6th. Finally, Wells Fargo & Company decreased their price objective on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, October 27th. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $36.39.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.